Lynda Wyld Selected Research

Animal Assisted Therapy

1/2021	Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life.
1/2021	Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer.
1/2021	Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer.
12/2015	The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK.
12/2015	The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer.
8/2015	The information and decision support needs of older women (>75 yrs) facing treatment choices for breast cancer: a qualitative study.
6/2015	Understanding older women's decision making and coping in the context of breast cancer treatment.
4/2008	Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynda Wyld Research Topics

Disease

19	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2007
3	Neoplasms (Cancer) 01/2021 - 12/2015
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 01/2021
2	Nausea 01/2021 - 05/2014
2	Fatigue 01/2021 - 01/2021
1	Triple Negative Breast Neoplasms 01/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021
1	Vomiting 01/2021
1	Constipation 01/2021
1	Dyspareunia 01/2019
1	Unilateral Breast Neoplasms 01/2018
1	Liposarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Genomic Instability 01/2018
1	Frailty 07/2017
1	Headache (Headaches) 05/2014
1	Exanthema (Rash) 05/2014
1	Alopecia (Baldness) 05/2014
1	Thrombophlebitis 05/2014
1	Vertigo (Positional Vertigo) 05/2014
1	Cystitis 05/2014
1	Sleepiness 05/2014
1	Vaginal Discharge 05/2014
1	Mastodynia 05/2014
1	Pruritus (Itching) 05/2014
1	Dyspepsia (Indigestion) 05/2014
1	Philadelphia Chromosome 03/2011
1	Intra-Abdominal Hypertension 03/2011
1	Respiratory Acidosis 03/2011

Drug/Important Bio-Agent (IBA)

2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2018
2	Tamoxifen FDA LinkGeneric 05/2014 - 04/2008
1	fisetinIBA 07/2020
1	navitoclaxIBA 07/2020
1	QuercetinIBA 07/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	pertuzumabIBA 01/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	N-hydroxysuccinimide suberic acid ester (DSIS)IBA 06/2015
1	GasesIBA 03/2011
1	Imatinib Mesylate (Gleevec)FDA Link 03/2011

Therapy/Procedure

10	Therapeutics 01/2021 - 10/2007
8	Animal Assisted Therapy 01/2021 - 04/2008
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Salpingo-oophorectomy 10/2021 - 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 01/2021
1	Radiotherapy 01/2021
1	Lasers (Laser) 01/2019
1	Mastectomy (Mammectomy) 01/2018
1	Neoadjuvant Therapy 01/2018
1	Adjuvant Chemotherapy 01/2017
1	Activities of Daily Living (ADL) 12/2015
1	Splenectomy 03/2011
1	Laparotomy 03/2011